As of April 2024 Verastem Oncology has a market cap of $0.23 Billion. This makes Verastem Oncology the world's 6783th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.23 B | 13.32% |
2023 | $0.20 B | 143.23% |
2022 | $84.56 M | -77.36% |
2021 | $0.37 B | 3.28% |
2020 | $0.36 B | 236.83% |
2019 | $0.10 B | -56.71% |
2018 | $0.24 B | 59.84% |
2017 | $0.15 B | 274.47% |
2016 | $41.43 M | -39.7% |
2015 | $68.71 M | -72.42% |
2014 | $0.24 B | -13.71% |
2013 | $0.28 B | 61.31% |
2012 | $0.17 B |
On Apr 24th, 2024 the market cap of Verastem Oncology was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Pfizer PFE | $143.30 B | 61,382.51% | ๐บ๐ธ USA |
LabCorp LH | $16.68 B | 7,058.05% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $83.53 B | 35,740.95% | ๐ฌ๐ง UK |
Curis CRIS | $86.05 M | -63.08% | ๐บ๐ธ USA |